The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Fourth Oaktree Letter

6 Jun 2018 16:49

RNS Number : 5575Q
Ranger Direct Lending Fund PLC
06 June 2018
 

Ranger Direct Lending Fund plc

("Ranger" or the "Company")

 

Response to Fourth Oaktree Letter

 

The independent directors of Ranger ("Independent Directors") note the announcement from Oaktree Capital Management, L.P. ("Oaktree") today.

 

The Independent Directors welcome that Oaktree now acknowledges that a winding up of Ranger is not the only option for the future of the Company and responds to Oaktree's other comments below.

 

Review Process

The investment management review process ("the process") has been run by the Independent Directors who note that Oaktree is the only major shareholder in Ranger not to take up the opportunity of a presentation from Ares Management LLC ("Ares") on the detail of its proposed future investment strategy. The Independent Directors believe that the new investment policy will enhance the capital stability of the Company going forward to the benefit of both ordinary shareholders and Zero Dividend Preference ("ZDP") shareholders.

 

During the process, the Independent Directors have looked to balance the interests of all stakeholders. The process involved two rounds of written submissions from potential investment managers, including details dealing with the legitimate interests of the ZDP shareholders. Oaktree was invited to participate in the process but declined. It is the Independent Director's view that if Oaktree had fully engaged in the process, it would understand how the Independent Board conducted a robust, fair and balanced process.

 

The Independent Directors and their advisers continue to be in positive discussions with shareholders on the Ares proposal and related matters. Ares is also in dialogue with shareholders on the detail of the proposed new investment policy. The Independent Directors believe that the majority of shareholders want this level of engagement to be able to reach an informed view on the future of the Company.

 

Future of the Company

The Independent Directors welcome Oaktree's statement today that its nominees for Board positions "are committed to exploring all strategic alternatives for the Company in order to maximise value", and that they are willing to engage "with potential new managers including Ares". However, the Independent Directors have to reflect that this public pronouncement is not corroborated by Oaktree's recent conduct. In its open letter to shareholders of 4 May 2018, Oaktree concluded that a winding up of Ranger was the only way forward for the Company. Oaktree has since engaged in a disruptive campaign seeking to force through a winding up of the Company, irrespective of the interests of other longer-term shareholders.

 

Future Board Composition

The Independent Directors of Ranger have engaged actively with shareholders during the process on the future composition of the Board. The EGM circular will include a commitment to appoint additional non-executive directors with relevant experience, after further consultation with shareholders. If appointed, Ares will not have a Board representative, and non-independent non-executive director, Mr. K. Scott Canon, the CEO of Ranger Capital Group, has confirmed he will resign as a director of the Company following the EGM. The Independent Directors welcome the recommendation by Institutional Shareholder Services (ISS), that clients vote against resolutions 8,9.10,11 and 12 at the AGM to be held on 19 June 2018.

 

Recommendation

The Board will publish all relevant information ahead of shareholders making a decision on the AGM resolutions relating to the appointment and removal of directors. As stated in the notice of the meeting, the Board recommends that shareholders vote against resolutions 8, 9, 10, 11 and 12 at the AGM to be held on 19 June 2018.

 

An EGM circular will be sent to shareholders following regulatory approval.

 

Contacts:

 

Ranger Direct Lending Fund plc

Christopher Waldron (Chairman)

 

Via Kinmont

Kinmont

Gavin Kelly

 

Tel: +44 (0)20 7087 9134

 

Liberum

Joshua Hughes

 

Tel: +44 (0)20 3100 2000

Redleaf (for media enquiries)

Robin Tozer

Tel: + 44 (0) 20 3757 6867

ranger@redleafpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBUGDLLSGBGIL
Date   Source Headline
31st Mar 20174:35 pmRNSPrice Monitoring Extension
30th Mar 20172:24 pmRNSC Share Conversion Ratio and Timetable
22nd Mar 201712:53 pmRNSC Share Conversion
22nd Mar 201712:50 pmRNSNet Asset Value(s)
22nd Mar 201712:50 pmRNSMonthly Update
9th Mar 20172:46 pmRNSMonthly Update
9th Mar 20172:44 pmRNSNet Asset Value(s)
27th Feb 20177:00 amRNSReplacement: Dividend Declaration
24th Feb 20177:00 amRNSDividend Declaration
9th Feb 20175:16 pmRNSMonthly Update
9th Feb 20175:16 pmRNSNet Asset Value(s)
20th Jan 20177:00 amRNSPortfolio update - Argon Credit
3rd Jan 20172:10 pmRNSTotal Voting Rights
28th Dec 20163:48 pmRNSMonthly Update
28th Dec 20163:45 pmRNSNet Asset Value(s)
22nd Dec 201611:07 amRNSPortfolio update - Argon Credit
21st Dec 20165:21 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSAdmission of C Shares
13th Dec 20164:00 pmRNSResult of Open Offer and Placing
21st Nov 20164:03 pmRNSPublication of a Prospectus
18th Nov 20163:22 pmRNSMonthly Update
18th Nov 20163:21 pmRNSNet Asset Value(s)
14th Nov 20167:00 amRNSPROPOSED OPEN OFFER, PLACING AND PLACING PROGRAMME
9th Nov 20167:00 amRNSDividend Declaration
4th Nov 20167:00 amRNSAdmission of ZDP Shares
2nd Nov 20167:00 amRNSResults of ZDP Share Placing
24th Oct 20165:39 pmRNSPublication of a Prospectus
21st Oct 20163:11 pmRNSMonthly Update
21st Oct 20163:10 pmRNSNet Asset Value(s)
29th Sep 20162:39 pmRNSMonthly Update
29th Sep 20162:39 pmRNSNet Asset Value(s)
16th Sep 20167:00 amRNSCorporate Update
15th Sep 20167:00 amRNSHalf-year Report
25th Aug 20167:00 amRNSNet Asset Value(s)
25th Aug 20167:00 amRNSMonthly Update
10th Aug 20167:00 amRNSInterim Dividend
1st Aug 20167:00 amRNSAdmission of ZDP Shares and First Day of Dealing
26th Jul 20163:21 pmRNSPublication of ZDP Prospectus
25th Jul 20164:46 pmRNSMonthly Update
25th Jul 20164:35 pmRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSZDP Share Issue Update
28th Jun 20162:57 pmRNSMonthly Update
28th Jun 20162:47 pmRNSNet Asset Value(s)
10th Jun 20165:00 pmRNSHolding(s) in Company
10th Jun 20164:55 pmRNSHolding(s) in Company
6th Jun 20167:00 amRNSProposed ZDP Share Issue
24th May 20165:25 pmRNSResult of AGM
23rd May 20169:00 amRNSMonthly Update
23rd May 20168:55 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.